{
    "clinical_study": {
        "@rank": "72416", 
        "brief_summary": {
            "textblock": "OBJECTIVES: I.  Assess the safety and efficacy of NTBC in children with tyrosinemia I.\n\n      II. Evaluate the effects of NTBC on survival, rate of neurologic crises, improvement in\n      renal tubular damage, reduction in the need for liver transplantation, and reduction in the\n      development of hepatocarcinoma in these patients."
        }, 
        "brief_title": "Study of NTBC for Tyrosinemia I", 
        "condition": "Tyrosinemia I", 
        "condition_browse": {
            "mesh_term": "Tyrosinemias"
        }, 
        "detailed_description": {
            "textblock": "PROTOCOL OUTLINE: Patients are stratified according to age at onset of symptoms (0-2 months\n      vs 2-6 months vs greater than 6 months).\n\n      Patients receive oral NTBC twice a day.  Treatment continues in the absence of unacceptable\n      toxicity.\n\n      Patients are followed once a month for 6 months, then every 3 months thereafter."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "-  Confirmed diagnosis of tyrosinemia Detected through newborn screening before the\n             onset of symptoms OR Diagnosed on the basis of symptoms (liver disease, neurological\n             crises, growth failure) and succinylacetone in urine or blood and/or\n             fumarylacetoacetate dehydratase deficiency in cultured fibroblasts or liver biopsy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "17 Years", 
            "minimum_age": "N/A"
        }, 
        "enrollment": "20", 
        "firstreceived_date": "October 18, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00004443", 
            "org_study_id": "199/13443", 
            "secondary_id": "UWASH-FDR001445"
        }, 
        "intervention": {
            "intervention_name": "NTBC", 
            "intervention_type": "Drug"
        }, 
        "keyword": [
            "inborn errors of metabolism", 
            "rare disease", 
            "tyrosinemia I"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "location": [
            {
                "contact": {
                    "last_name": "Markus Grompe", 
                    "phone": "503-494-6888"
                }, 
                "facility": {
                    "address": {
                        "city": "Portland", 
                        "country": "United States", 
                        "state": "Oregon", 
                        "zip": "97201-3098"
                    }, 
                    "name": "Oregon Health Sciences University"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "C. Ronald Scott", 
                    "phone": "206-543-3370"
                }, 
                "facility": {
                    "address": {
                        "city": "Seattle", 
                        "country": "United States", 
                        "state": "Washington", 
                        "zip": "98195"
                    }, 
                    "name": "University of Washington School of Medicine"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Grant Mitchell", 
                    "phone": "514-345-4931"
                }, 
                "facility": {
                    "address": {
                        "city": "Montreal", 
                        "country": "Canada", 
                        "state": "Quebec", 
                        "zip": "H3T 1C5"
                    }, 
                    "name": "Hopital Sainte Justine"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Canada"
            ]
        }, 
        "overall_official": {
            "affiliation": "University of Washington", 
            "last_name": "C. Ronald Scott", 
            "role": "Study Chair"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "N/A", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00004443"
        }, 
        "source": "FDA Office of Orphan Products Development", 
        "sponsors": {
            "collaborator": {
                "agency": "University of Washington", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "FDA Office of Orphan Products Development", 
                "agency_class": "U.S. Fed"
            }
        }, 
        "start_date": "October 1998", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2000"
    }, 
    "geocoordinates": {
        "Hopital Sainte Justine": "45.509 -73.554", 
        "Oregon Health Sciences University": "45.523 -122.676", 
        "University of Washington School of Medicine": "47.606 -122.332"
    }
}